• 대한전기학회:학술대회논문집
• /
• 대한전기학회 2006년도 제37회 하계학술대회 논문집 D
• /
• pp.1997-1998
• /
• 2006

In this paper, we propose a remote control system which is used by internet network system in the small water booster supply. So far, TMTC(Tele Metering Tele Control) has been used to control and monitor small water booster pump. But it is possible and easy to control and observe local booster panel with the rapid development of internet, This new system is to provide operators and managers with sufficient information and control in order to implement the operation in an efficient and economical way. This system consists of three parts that are controller, netpump server and netview client. Controller has a dual architecture. The motive for installing controller is the continuous production and supply of drinking water.

• 대한전기학회:학술대회논문집
• /
• 대한전기학회 2003년도 하계학술대회 논문집 A
• /
• pp.293-295
• /
• 2003

KEPCO's high voltage distribution power line laid under the ground near to the J-booster pumping station that supply water for living. Lightening rod equipment does not installed at the J-booster pumping station because KEPCO's over head ground wire for protection functions as a lightening rod equipment. In this study, it is concerned whether KEPCO's over head ground wire for protect the distribution power line affect to the J-booster pumping station which is installed for reduce the damage from the direct and indirect lightening. If KEPCO's protection area does not affect to the J-pumping station, it is plan to examine the construction method of lightening rod protection angle and lightening rod equipment and to suggest the optimum protection plan using the surrounding structure based on the suitability of protection area.

• 한국지열·수열에너지학회논문집
• /
• 제11권3호
• /
• pp.7-12
• /
• 2015

Currently water supply system with water storage is generally applied except for small building such as single-family houses, and water supply system on replacing water storage installed system by direct connecting system has been increasing because of sanitary and energy-saving aspects. The purpose of this study is to evaluate energy-saving and environmental efficiency of direct connecting booster pump system in comparison with the water storage installed system. The architectural condition of the evaluation subject is ten-story apartment house in which sixty households live. To calculate the power consumption of the pump, the volume of water supply was determined from existing data and other data, such as head, efficiency of the pump, was the value used for general application in design office. The power consumption of the water supply pump for one day was 8.5 kWh for direct connecting booster pump system, and 22.5 kWh for water storage installed system, and the former system showed energy savings of 62% compared to the latter system. Reduced power consumption also leads to reduction of $CO_2$ emission. According to the criteria presented in the Korea Energy Management Corporation, reducing the 2,410 kg $CO_2$ emission is possible per year.

• Clinical and Experimental Vaccine Research
• /
• 제12권4호
• /
• pp.337-345
• /
• 2023

Purpose: The global fight against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to widespread vaccination efforts, yet the optimal dosing schedule for SARS-CoV-2 vaccines remains a subject of ongoing research. This study aims to investigate the effectiveness of administering two booster doses as the third and fourth doses at different intervals to enhance vaccine protection. Materials and Methods: This study was conducted at a military regional hospital operated by the Ministry of National Defense in Taiwan. A cohort of vaccinated individuals was selected, and their vaccine potency was assessed at various time intervals following their initial vaccine administration. The study participants received booster doses as the third and fourth doses, with differing time intervals between them. The study monitored neutralizing antibody titers and other relevant parameters to assess vaccine efficacy. Results: Our findings revealed that the potency of the SARS-CoV-2 vaccine exhibited a significant decline 80 days after the initial vaccine administration. However, a longer interval of 175 days between booster injections resulted in significantly higher neutralizing antibody titers. The individuals who received the extended interval boosters exhibited a more robust immune response, suggesting that a vaccine schedule with a 175-day interval between injections may provide superior protection against SARS-CoV-2. Conclusion: This study underscores the importance of optimizing vaccine booster dosing schedules to maximize protection against SARS-CoV-2. The results indicate that a longer interval of 175 days between the third and fourth doses of the vaccine can significantly enhance the neutralizing antibody response, potentially offering improved protection against the virus. These findings have important implications for vaccine distribution and administration strategies in the ongoing battle against the SARS-CoV-2 pandemic. Further research and largescale trials are needed to confirm and extend these findings for broader public health implications.

• Clinical and Experimental Vaccine Research
• /
• 제13권1호
• /
• pp.35-41
• /
• 2024

Purpose: The effectiveness of coronavirus disease 2019 (COVID-19) vaccination schemes and the combination of vaccines of various platforms for administering booster doses is still being studied since it will depend on the population's response to vaccines. We aimed to evaluate the safety, protection, and immunogenicity of the Salvadorean population's third dose booster COVID-19 vaccine and the potential benefit of homologous vs. heterologous regimens. Materials and Methods: This is an analytical observational cohort study in a population aged 18 to 65 years that was primarily vaccinated with AstraZeneca, Sinovac, or Pfizer/BioNTech. Volunteers were recruited (n=223) and followed up for 3 months after receiving the 3rd vaccine (BNT162b2) as a booster. Adverse reactions were monitored, serum anti-spike immunoglobulin G (IgG) was assessed by chemiluminescence, and a polymerase chain reaction was carried out when subjects developed clinical signs. Results: The cohorts finally included 199 participants, and we observed only mild adverse effects in all cohorts. A significant increase in specific IgG levels was found after the booster dose in all cohorts. The heterologous scheme with Sinovac showed the greatest increase in antibody titer, and a decrease was observed in all participants after 3 months. During the follow-up period, 30 participants showed symptomatology compatible with COVID-19, but only four were laboratory-confirmed and they showed mild clinical signs. Conclusion: These findings indicate that the booster doses used were safe and promoted an immediate increase in immunogenicity, which decreased over time. The heterologous regimen showed stronger immunogenicity compared to the messenger RNA-based homologous scheme.

• 한국학교수학회논문집
• /
• 제10권1호
• /
• pp.27-43
• /
• 2007

본 연구의 목적은 이공계 대학생들에게 수학에 대한 동기유발과 수학학습에 도움을 주기 위하여 기반 학습 시스템을 개발하는 것이다. 이를 위하여 Mathematica와 웹 연동을 가능하게 해주는 webMathematica를 사용하여 이공계 대학생을 위한 미적분학습용 웹 콘텐츠 시스템인 MathBooster를 제작하였다. 이공계 대학생을 위한 웹 콘텐츠의 구성은 먼저 미적분의 개념을 그래프와 같은 시각화한 그림을 사용함으로써 흥미와 동기의 유발, 그리고 개념 형성을 위해 요소 지식에 관련된 내용을 수식과 텍스트로 제시하였다. 또한 단계별 풀이과정이 제시되는 예제를 제공하여 개념의 이해를 통한 응용력을 배양하도록 콘텐츠를 제공하였다. 학습자의 이해력을 확인하기 위하여 퀴즈를 제공하였으며 베이지언 네트워크를 이용하여 학습자의 퀴즈 풀이 결과에 따라 해당 콘텐츠에 대한 학습의 이해 정도를 진단하는 기능을 개발하였다. 이공계 수학용 웹 콘텐츠의 형성평가를 위하여 MathBooster에 대한 사용자의 반응, 화면구성의 적절성, 실습하기 모드의 만족도, 퀴즈, 진단결과, 피드백 만족도 등의 네 영역으로 구분하여 설문지를 작성하였다. MathBooster의 실습을 마친 이공계 학생을 대상으로 설문지를 배포하였으며 영역별로 통계 처리한 결과 MathBooster 사용에 대한 높은 만족도를 보여 주었다. 이 결과에 따라 향후 시스템을 수정보완 할 과제를 제시하였다.

• 한국추진공학회지
• /
• 제21권2호
• /
• pp.72-82
• /
• 2017

무노즐 부스터는 통합형 로켓 램제트 추진기관에 적용되는 구성품 중 하나이다. 무노즐 고체 부스터의 성능을 예측하기 위해서 간단한 이론적 해석이 L/D=5, 6, 7, 9, 11, 그리고 13에 적용되었다. 연소가스 유동 효과 때문에 경도를 증가시키기 위해서 금속함량이 높은 Al-HTPB 및 Zr-HTPB 추진제가 사용되었다. 간단한 이론 해석과 시험결과 사이의 경향은 유사하게 나타났다.

• 한국추진공학회지
• /
• 제22권4호
• /
• pp.91-98
• /
• 2018

본 연구에서는 중첩된 두 비행물체에서 단분리 시 일어나는 주위 유동장 분석에 초점을 맞춰 해석을 수행하였다. 수치 해석을 위하여 정지된 비행체에서 분리되는 실린더 형태의 부스터를 중첩격자를 이용하여 모델링 하였으며 상용해석코드인 $CFD-FASTRAN^{TM}$을 사용하여 계산하였다. 실제 현상을 모사하기 위해서는 부스터에 대한 스프링 반발력, 중력, 상대 속도 등의 고려가 필수적인 요소였다. 연구결과, 부스터의 분리 시간은 비행 마하수와 받음각이 증가함에 따라 감소하는 것을 확인할 수 있었으며, 현재까지의 결과를 종합하여 볼 때 본 연구에서 수행한 모델링과 경계조건 등의 구성이 비행시험의 안전한 부스터 분리와 이후 시퀀스를 예측하는데 많은 도움을 줄 것으로 판단된다.

• Clinical and Experimental Pediatrics
• /
• 제54권4호
• /
• pp.163-168
• /
• 2011

Purpose: The purpose of this study was to evaluate the immune response to serotype 19A in children aged 12-23 months after immunization of the 19F containing 7-valent pneumococcal conjugate vaccine (PCV7). Methods: Blood samples from a total of 45 subjects (age 12-23 months) were included in the study. Subjects were categorized according to immunization status into three groups as follows: 18 subjects with 3 primary doses and 1 booster dose of PCV7 (booster group), 21 subjects with 3 primary doses before 12 months of age (primary group), and 6 subjects with no vaccination history of PCV7 (control group). An ELISA and opsonophagocytic killing assay (OPKA) was done to evaluate the immune responses against serotypes 19F and 19A. Results: According to the ELISA, all subjects had antibody titers ${\geq}0.35{\mu}g/mL$ for serotypes 19F and 19A in the booster and primary group and 83.0% and 66.7% in the control group, respectively. According to the OPKA, subjects with opsonic activity (${\geq}20$) against serotypes 19F and 19A were 100% and 61.1% of the subjects in the booster group and 66.7% and 19.0% in the primary group, respectively. No subjects in the control group had opsonic antibodies against both serotypes. Conclusion: In conclusion, in children 12-23 months age who were previously vaccinated with PCV7, a cross-reactive immune response is elicited against serotype 19A after a primary series of 3 doses in a small proportion of subjects, and this response is amplified after booster vaccination.

• 대한바이러스학회지
• /
• 제30권1호
• /
• pp.11-18
• /
• 2000

Since $Hantavax^{TM}$, formalin inactivated Hantaan virus vaccine (10,240 ELISA units/ml), has been developed in 1990 to prevent against haemorrhagic fever with renal syndrome (HFRS) caused by Hantaan or Seoul virus, it has been commercially available in Korea. Twenty-one healthy people were booster shot once and twice after primary basic vaccination with $Hantavax^{TM}$. Seroconversion rates were measured by immunofluorescent antibody technique (IFAT), enzyme-linked immunosorbent assay (ELISA), high density composite particle agglutination (HDPA), and plaque reduction neutralization test (PRNT). Seroconversion rates of 21 vaccinees at one year after primary basic vaccination were 52.3%, 95.2%, 0.0%, 47.6%, and 28.6%, and 13 vaccinees at one month after 1st booster vaccination were 100%, 100%, 30.7%, 100% and 100% by IFAT, ELISA (IgG, IgM), HDPA and PRNT, respectively. Seroconversion rates declined slightly by twenty months, and they were 84.6%, 92.3%, 0.0%, 84.6% and 69.2% by IFAT, ELISA (IgG, IgM), HDPA and PRNT, respectively. Seroconversion rates of 9 vaccinees at three months after 2nd booster vaccination were 100%, 100%, 0.0%, 100%, and 88.9%, and 16 vaccinees at one year after the 2nd booster vaccination were 87.5%, 93.8%, 0.0%, 87.5% and 81.3% by IFAT, ELISA (IgG, IgM), HDPA and PRNT, respectively. Based on the above result $Hantavax^{TM}$ has proved a vigorous anamnestic response after the 1st and the 2nd booster vaccination and has persisted higher fluorescence, agglutination and neutralizing antibody titers in vaccinees.